These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10838021)

  • 21. Improvement of solubility and dissolution rate of indomethacin by solid dispersions in Gelucire 50/13 and PEG4000.
    El-Badry M; Fetih G; Fathy M
    Saudi Pharm J; 2009 Jul; 17(3):217-25. PubMed ID: 23964164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation, characterization, and dissolution studies of ibuprofen solid dispersions using polyethylene glycol (PEG), talc, and PEG-talc as dispersion carriers.
    Khan GM; Jiabi Z
    Drug Dev Ind Pharm; 1998 May; 24(5):455-62. PubMed ID: 9876608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.
    Dhumal RS; Biradar SV; Aher S; Paradkar AR
    J Pharm Pharmacol; 2009 Jun; 61(6):743-51. PubMed ID: 19505364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation, characterization and tableting of cilnidipine solid dispersions.
    Hu L; Song W; Niu F; Jiao K; Jia Z
    Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physicochemical characterization of nimodipine-polyethylene glycol solid dispersion systems.
    Barmpalexis P; Kachrimanis K; Georgarakis E
    Drug Dev Ind Pharm; 2014 Jul; 40(7):886-95. PubMed ID: 23611475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of dissolution rate of valdecoxib using solid dispersions with polyethylene glycol 4000.
    Liu C; Liu C; Desai KG
    Drug Dev Ind Pharm; 2005 Jan; 31(1):1-10. PubMed ID: 15704852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relating solubility data of parabens in liquid PEG 400 to the behaviour of PEG 4000-parabens solid dispersions.
    Unga J; Tajarobi F; Norder O; Frenning G; Larsson A
    Eur J Pharm Biopharm; 2009 Oct; 73(2):260-8. PubMed ID: 19508891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physicochemical characterization of artemether solid dispersions with hydrophilic carriers by freeze dried and melt methods.
    Ansari MT; Karim S; Ranjha NM; Shah NH; Muhammad S
    Arch Pharm Res; 2010 Jun; 33(6):901-10. PubMed ID: 20607495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular interaction between glimepiride and Soluplus®-PEG 4000 hybrid based solid dispersions: Characterisation and anti-diabetic studies.
    Reginald-Opara JN; Attama A; Ofokansi K; Umeyor C; Kenechukwu F
    Int J Pharm; 2015 Dec; 496(2):741-50. PubMed ID: 26581773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diclofenac salts, II. Solid dispersions in PEG6000 and Gelucire 50/13.
    Fini A; Moyano JR; Ginés JM; Perez-Martinez JI; Rabasco AM
    Eur J Pharm Biopharm; 2005 May; 60(1):99-111. PubMed ID: 15848062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and Characterization of Solid Dispersions of Artemether by Freeze-Dried Method.
    Ansari MT; Hussain A; Nadeem S; Majeed H; Saeed-Ul-Hassan S; Tariq I; Mahmood Q; Khan AK; Murtaza G
    Biomed Res Int; 2015; 2015():109563. PubMed ID: 26097842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physicochemical and dissolution studies of simvastatin solid dispersions with Pluronic F127.
    Karolewicz B; Gajda M; Owczarek A; Pluta J; Górniak A
    Pharmazie; 2014 Aug; 69(8):589-94. PubMed ID: 25158569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Approach to Enhance Dissolution Rate of Tamoxifen Citrate.
    SreeHarsha N; Hiremath JG; Chilukuri S; Aitha RK; Al-Dhubiab BE; Venugopala KN; Alzahrani AM; Meravanige G
    Biomed Res Int; 2019; 2019():2161348. PubMed ID: 30800663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation, characterization and in vitro dissolution studies of solid dispersion of meloxicam with PEG 6000.
    Vijaya Kumar SG; Mishra DN
    Yakugaku Zasshi; 2006 Aug; 126(8):657-64. PubMed ID: 16880724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and characterization of etoricoxib-polyethylene glycol 4000 plus polyvinylpyrrolidone K30 solid dispersions.
    Suhagia BN; Patel HM; Shah SA; Rathod I; Parmar VK
    Acta Pharm; 2006 Sep; 56(3):285-98. PubMed ID: 19831278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation and pharmacokinetics of gelucire solid dispersions of flurbiprofen.
    Daravath B; Tadikonda RR; Vemula SK
    Drug Dev Ind Pharm; 2015; 41(8):1254-62. PubMed ID: 25039470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and characterization of spironolactone-loaded gelucire microparticles using spray-drying technique.
    Yassin AE; Alanazi FK; El-Badry M; Alsarra IA; Barakat NS; Alanazi FK
    Drug Dev Ind Pharm; 2009 Mar; 35(3):297-304. PubMed ID: 18821154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphism of Indomethacin in Semicrystalline Dispersions: Formation, Transformation, and Segregation.
    Van Duong T; Lüdeker D; Van Bockstal PJ; De Beer T; Van Humbeeck J; Van den Mooter G
    Mol Pharm; 2018 Mar; 15(3):1037-1051. PubMed ID: 29307188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studies.
    Eedara BB; Veerareddy PR; Jukanti R; Bandari S
    Drug Dev Ind Pharm; 2014 Aug; 40(8):1030-43. PubMed ID: 23738504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.